trials of interest in newly diagnosed myeloma presented at ims 2024
Published 20 hours ago • 43 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
1:36
the use of outpatient cilta-cel in the treatment of multiple myeloma
-
5:15
the promise of immunotherapies in t-cell lymphoma
-
1:16
the efficacy of car t-cell therapy in richter's transformation
-
1:45
long-term survival of patients with cll treated with ibrutinib compared to age-matched controls
-
1:43
the importance of understanding cellular functionality to develop biological therapies for cll
-
2:43
mrd as an early endpoint for accelerated approval: a success story
-
9:25
mgus diagnosis: a step-by-step approach
-
2:56
meet dr. stephan moll: hematologist
-
2:46
what advice would you give to people considering a career in haematology?
-
1:18
the talisman study: prophylactic treatment for talquetamab-related oral toxicity in myeloma
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:35
the value of ctcs and cfdna as novel biomarkers in multiple myeloma
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
8:57
outcomes of sct in t-all and t-lbl
-
1:39
session highlights: the value of clinical hematology research groups
-
1:25
prognostic and predictive biomarkers in cll and their potential in guiding treatment decisions
-
4:52
the collaboration of the ebmt and isct for the development and monitoring of atmps and soho
-
2:18
phase i/ii tg01 study exploring the use of vaccination in ras-mutated myeloma
-
1:55
unmet needs in dlbcl: frontline therapy, car-t optimization, and clinical trial inclusion
-
2:13
personalizing the timing of sct in patients with myelofibrosis